ALM Equity AB
F:I53
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ALM Equity AB
F:I53
|
SE |
|
Astellas Pharma Inc
F:YPHA
|
JP |
|
Lifecore Biomedical Inc
F:LDE
|
US |
|
V
|
Vallourec SA
F:VACD
|
FR |
|
B
|
Bumi Resources Minerals Tbk PT
XMUN:BUR
|
ID |
|
V
|
Vallourec SA
F:VACE
|
FR |
|
M
|
Memphasys Ltd
F:IG7
|
AU |
|
R
|
RPC Inc
F:RLD
|
US |
|
M
|
Memphasys Ltd
ASX:MEM
|
AU |
|
Santec Holdings Corp
F:8AU
|
JP |
Shareholder Yield
Current shareholder yield for 
I53 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
I53 Price
ALM Equity AB
| Average Annual Return | -34.27% |
| Standard Deviation of Annual Returns | 40.27% |
| Max Drawdown | -94% |
| Market Capitalization | 656.2m EUR |
| Shares Outstanding | 11 685 200 |
| Percentage of Shares Shorted |
N/A
|
